AdvancedAdvT stock closed at £1.70 after the H1 2027 earnings drop, capping a choppy spell with the share price down about 6% over seven days and 8% over a month. The immediate tape suggests that investors are cautious, while the income statement presents a different picture. Basic earnings per share for the half came in at £0.0599 and net income reached £7.995m, set against a P/E of 23x that now appears more closely linked to profit delivery than to hype.

Like the earnings power at AdvancedAdvT but wary of paying 23x P/E for a stock that just had a choppy month? Compare that setup with a 15 high quality undervalued stocks to see how other profitable companies with solid balance sheets are currently priced.

H1 2027 Earnings Summary

• Revenue (H1 2027 vs H1 2026): £28.806m vs. £25.436m (up about 13.3%)
• Net Income (H1 2027 vs H1 2026): £7.995m vs. £2.93m (up about 172.9%)
• Basic EPS (H1 2027 vs H1 2026): £0.0599 vs. £0.021736 (up about 175.6%)
• Net Margin (TTM vs prior TTM): 17% vs. 12.2% (wider profitability on trailing twelve month earnings)

Earnings look strong for AdvancedAdvT, yet cash generation can tell a very different story for anyone thinking about what they are actually paying for the business. When you focus on AdvancedAdvT's cash flows instead of reported profit, the stock could be a solid 19% overvalued.

AdvancedAdvT earnings tilt the balance to growth

For a software and AI themed group like AdvancedAdvT, the combination of £28.806m in H1 revenue and £7.995m in profit points to a business model that is converting sales into earnings with more conviction. Net income and basic EPS both sit well ahead of last year’s half. A wider trailing net margin at 17% versus 12.2% on the prior twelve months also leans in favour of the recurring software and compliance story actually pulling through into the numbers.

Short term share weakness keeps the risk debate alive

The share price has slipped about 5.6% over seven days and 8.1% over a month, which indicates that some investors are still uneasy despite the headline progress in profit. That tension between falling returns on the ticker and healthier earnings can feed the bearish view that sentiment around smaller software and healthcare compliance players remains fragile. It also leaves open the argument that any stumble in future deal flow or cash conversion could affect a stock that has already been under pressure.

With earnings moving up and the share price still under pressure, the real question is whether AdvancedAdvT has the balance sheet strength and cash profile to absorb any shock. Check the full financial health analysis of AdvancedAdvT stock to see how liquidity, debt and cash runway stack up against those profits.

Spot Check Three Quiet Setups

AdvancedAdvT just showed how a solid earnings story can sit beside a hesitant share price. The real opportunity is finding stocks that could be undervalued before the market corrects them.

• Company 1 - 18% below our estimate - win larger infrastructure and data center foundation projects by enforcing strict project risk controls.
• Company 2 - 38% below our estimate - grow fee related earnings as wealth products and co investments attract client capital.
• Company 3 - 28% below our estimate - convert a long dated order book in secure communications and maritime programs into higher margins.

Three companies from the same screener. Open the full list of 15 companies trading below our fair value estimates →

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.